2 results
Approved WMORecruiting
The objective of the study is to compare conventional therapy with biological therapy in patients with early rheumatoid arthritis.
Approved WMORecruiting
The primary objective is to investigate if IMO-2125 is capable of a) lowering the number of tumor positive SLN and b) inducing a loco-regional and systemic immune response. The secondary objective is to investigate RFS and OS at 18 months, 24 months…